IL-6 — Drug Target
All drugs that target IL-6 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
IL-6 inhibitor monoclonal antibody
Phase 3 pipeline (1)
- Placebo (ziltivekimab) · Novo Nordisk A/S · IL-6 inhibitor monoclonal antibody · Cardiovascular
Ziltivekimab is a monoclonal antibody that inhibits interleukin-6 (IL-6) signaling to reduce inflammation.